Catheter ablation should be performed in asymptomatic patients with Wolff-Parkinson-White syndrome

Circulation

Volumn 112, Issue 14, 2005, Pages 2207-2215

  Pappone, Carlo ^a   Santinelli, Vincenzo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATHETER ABLATION; CONSENSUS DEVELOPMENT; DISEASE COURSE; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TEST; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE FIBRILLATION; HIGH RISK PATIENT; HISTORY; HUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; WOLFF PARKINSON WHITE SYNDROME;

CATHETER ABLATION; HEART FUNCTION TESTS; HUMANS; REPRODUCIBILITY OF RESULTS; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 26944467885     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Spria R, Guize L, Chretien JM, Le Heuzey JY, Lavergne T, Desnos M, Hagege A, Guerre Y. The natural history of 270 cases of Wolff-Parkinson-White syndrome in a survey of the general population. Arch Mal Coeur Vaiss. 1989;82:331-336.
2. Fitzsimmons PJ, McWhirter PD, Peterson DW, Kruyer WB. The natural history of Wolff-Parkinson-White syndrome in 228 military aviators: a long-term follow-up of 22 years. Am Heart J. 2001;142:530-536.
3. Leitch JW, Klein GJ, Yee R, Murdock C. Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. Circulation. 1990;82:1718-1723.
4. Klein GJ, Yee R, Sharma AD. Longitudinal electrophysiologic assessment of asymptomatic patient with the Wolff-Parkinson-White electrocardiographic pattern. N Engl J Med. 1989;320:1229-1233.
5. Satbh M, Aizawa Y, Funazaki T, Niwano S, Ebe K, Miyajima S, Suzuki K, Aizawa M, Shibata A. Electrophysiologic evaluation of asymptomatic patients with the Wolff-Parkinson-White pattern. Pacing Clin Electrophysiol. 1989;12:413-420.
6. Brembilla-Perrot B, Ghawi R. Electrophysiological characteristics of asymptomatic Wolff-Parkinson-White syndrome. Eur Heart J. 1993;14: 511-515.
7. Munger TM, Packer DL, Hammill SC, Feldman BJ, Bailey KR, Ballard DJ, Holmes DR Jr, Gersh BJ. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953 to 1989. Circulation. 1993;87:866-873.
8. Beckman KJ, Gallastegui JL, Bauman JL, Hariman RJ. The predictive value of electrophysiologic studies in untreated patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1990;15:640-647.
9. Fukatani M, Tanigawa M, Mon M, Konoe A, Kadena M, Shimizu A, Hashiba K. Prediction of a fatal atrial fibrillation in patients with asymp-tomatic Wolff-Parkinson-White pattern. Jpn Circ J. 1990;54:1331-1339.
10. Berkman NL, Lamb LE. The Wolff-Parkinson-White electrocardiogram follow-up study of five to twenty-eight years. N Engl J Med. 1968;278: 492-494.
11. Goudevenos JA, Katsouras CS, Graekas G, Argiri O, Giogiakas V, Sideris DA. Ventricular pre-excitation in the general population: a study on the mode of presentation and clinical course. Heart. 2000;83:29-34.
12. Pappone C, Santinelli V, Rosanio S, Vicedomini G, Nardi S, Pappone A, Tortoriello V, Manguso F, Mazzone P, Gulletta S, Oreto G, Alfieri O. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern. J Am Coll Cardiol 2003;41:239-244.
13. Pappone C, Santinelli V, Manguso F, Augello G, Santinelli O, Vicedomini G, Gulletta S, Mazzone P, Tortoriello V, Pappone A, Dicandia C, Rosanio S. A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med. 2003;349:1803-1811.
14. Pappone C, Manguso F, Santinelli R, Vicedomini G, Sala S, Paglino G, Mazzone P, Lang CC, Gulletta S, Augello G, Santinelli O, Santinelli V. Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome. N Engl J Med. 2004;351:1197-1205.
15. Santinelli V, Turco P, de Paola M, Smimmo D, Palumbo G, Condorelli M. Long-term assessment of asymptomatic patients with ventricular pre-excitation: a pilot study. Circulation. 1990;82(suppl III):III-318. Abstract.
16. Gallagher JJ, Prichett ELC, Sealy WC, Kasell J, Wallace AG. The pre-excitation syndromes. Prog Cardiovasc Dis. 1978;20:285-327.
17. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2001;22:1374-1450.
18. Todd DM, Klein GJ, Krahn AD, Skanes AC, Yee R. Asymptomatic Wolff-Parkinson-White syndrome: is it time to revisit guidelines? J Am Coll Cardiol. 2003;41:245-248.
19. Zipes DP, DiMarco JP, Gillette PC, Jackman WM, Myerburg RJ, Rahimtoola SH, Ritchie JL, Cheitlin MD, Garson A Jr, Gibbons RJ. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures: a report of the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol. 1995;26:555-573.
20. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW Jr, Stevenson WG, Tomaselli GF, Antman EM, Smith SC Jr, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO Jr, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ, for the American College of Cardiology; American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias. ACC/AHA/ESC guidelines for the management of patients with Supraventricular arrhythmias: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation. 2003;108:1871-1909.
21. Calkins H, Sousa J, el-Atassi R, Rosenheck S, de Buitleir M, Kou WH, Kadish AH, Langberg JJ, Morady F. Diagnosis and cure of the Wolff-Parkinson- White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med. 1991;324: 1612-1618.
22. Jackman WM, Beckman KJ, McClelland JH, Wang X, Friday KJ, Roman CA, Moulton KP, Twidale N, Hazlitt HA, Prior MI. Treatment of Supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med. 1992;327:313-318.
23. Campbell RM, Strieper MJ, Frias PA, Collins KK, Van Hare GF, Dubin AM. Survey of current practice of pediatric electrophysiologists for asymptomatic Wolff-Parkinson-White syndrome. Pediatrics. 2003;111:e245-e247.
24. Milstein S, Sharma AD, Klein GJ. Electrophysiologic profile of asymptomatic Wolff-Parkinson-White pattern. Am J Cardiol. 1986;57: 1097-1100.
25. Rinne C, Klein GJ, Sharma AD, Yee R, Milstein S, Rattes MF. Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1987;60:576-579.
26. Morady F, Sledge C, Shen E, Sung RJ, Gonzales R, Sheinman MM. Electrophysiologic testing in the management of patients with the Wolff-Parkinson-White syndrome and atrial fibrillation. Am J Cardiol. 1985; 51:1623-1628.
27. Della Bella P, Brugada P, Talajic M, Lemery R, Torner P, Lezaun R, Dugernier T, Wellens HJ. Atrial fibrillation in patients with an accessory pathway: importance of the conduction properties of the accessory pathway. J Am Coll Cardiol. 1990;17:1352-1356.
28. Brembilla-Perrot B, Terrier de la Chaise A, Pichenè M, Aliot E, Cherrier F, Pernot C. Isoprenaline as an aid to the induction of catecholamine dependent supraventricular tachycardias during programmed stimulation. Br Heart J. 1989;61:348-355.
29. Dubin AM, Collins KK, Chiesa N, Hanisch D, Van Hare GF. The use of electrophysiologic testing to assess risk in children with Wolff-Parkinson-White syndrome. Cardiol Young. 2002;12:248-252.
30. Wellens HJJ, Brugada P, Roy D, Weiss J, Barr FW. Effect of isoproterenol on the anterograde refractory period of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. Am J Cardiol. 1982; 50:180-184.
31. Kitada M, Uheda K, Nakagawa T, Yamaguchi Y. Follow-up study of the arrhythmic graduates from the schools under the Heart Disease Program for students in Osaka. Jpn Circ J. 1984;48:1388-1392.
32. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of electrocardiographic pre-excitation in men: the Mannitoba follow-up study. Ann Inter Med. 1992;116:456-460.
33. Pietersen AH, Andersen ED, Sandoe E. Atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1992;70:38A-43A.
34. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med. 1979;301:1080-1085.
35. Montoya PT, Brugada P, Smeets J, Talajic M, Della Bella P, Lezaun R, vd Dool A, Wellens HJ, Bayes de Luna A, Oter R. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J. 1991;12:144-150.
36. Timmermans C, Smeets JL, Rodriguez LM, Vrouchos G, van den Dool A, Wellens HJ. Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1995;76:492-494.
37. Rodriguez LM, de Chillou C, Schlapfer J, Metzger J, Baiyan X, van den Dool A, Smeets JL, Wellens HJ. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol. 1992;70: 1213-1215.
38. Russel MW, Dorostkar PC, Macdonald D II. Incidence of catastrophic events associated with the Wolff-Parkinson-White syndrome in young patients: diagnostic and therapeutic dilemma. Circulation. 1993;88:2608. Abstract.
39. Deal BJ, Dick M, Beerman L. Cardiac arrest in young patients with Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol. 1995;18(ptII):815. Abstract.
40. Bromberg BI, Lindsay BD, Cain ME, Cox JL. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1996;27:690-695.
41. Sarubbi B, Scognamiglio G, Limongelli G, Mercuric B, Pacileo G, Pisacane C, Russo MG, Calabro R. Asymptomatic ventricular pre-excitation in children and adolescents: a 15 year follow up study. Heart. 2003;89:215-217.
42. Teo WS, Klein GJ, Guiraudon GM, Yee R, Leitch JW, McLellan D, Leather RA, Kim YH. Multiple accessory pathways in the Wolff-Parkinson-White syndrome as a risk factor for ventricular fibrillation. Am J Cardiol. 1991;15:889-891.
43. Van Hare GF, Javitz H, Carmelli D, Saul JP, Tanel RE, Fischbach PS, Kanter RJ, Schaffer M, Dunnigan A, Colan S, Serwer G, for the Pediatric Electrophysiology Society. Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol. 2004;15:759-770.
44. Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ. 1999;319:1492-1495.